Nocturia

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Recordati : Silodosin Approved By The European Commission For The Treatment Of The Signs And Symptoms Of Benign ...

Published February 4, 2010, 4:51 am, Medical News Today

Recordati announces that it has been granted Marketing Authorization by the European Commission for the medicinal products Urorec® and Silodyx™ 4 mg, 8 mg, hard capsules, intended for treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Following national post-authorization procedures, as relevant, product launch could take place by end 2010 or beginning 2011. Benign ...

Discover News | Full Story


Vantia Therapeutics' Lead Candidate VA106483 Enters Phase IIb Trial For Nocturia

Published February 3, 2010, 10:02 pm, DrugDiscoveryOnline

Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, recently announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia

Discover News | Full Story


Vantia Therapeutics' Lead Candidate VA106483 Enters Phase IIb Trial For Nocturia

Published February 3, 2010, 6:33 am, Medical News Today

Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia. The study is a randomised, double-blind, placebo-controlled study and is expected to recruit approximately 120 male patients at 20 centres in the US ...

Discover News | Full Story


RECORDATI : SILODOSIN (UROREC(R)/SILODYX) APPROVED BY THE EUROPEAN COMMISSION FOR THE TREATMENT OF THE SIGNS AND ...

Published February 3, 2010, 1:50 am, Marketwire

MILAN, ITALY--(Marketwire - February 3, 2010) - RECORDATI : SILODOSIN (UROREC®/SILODYXT) APPROVED BY THE EUROPEAN COMMISSION FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BPH (BENIGN PROSTATIC HYPERPLASIA) Milan, 3 February 2010 - Recordati announces that it has been granted Marketing Authorization by the European Commission for the medicinal products Urorec® and SilodyxT 4 mg, 8 mg, hard ...

Discover News | Full Story


Recordati : Silodosin (Urorec(R)/Silodyx) Approved by the European Commission for the Treatment of the Signs and ...

Published February 3, 2010, 1:46 am, Marketwire via Yahoo! Finance

MILAN, ITALY--(Marketwire - 02/03/10) - RECORDATI : SILODOSIN (UROREC/SILODYX) APPROVED BY THE EUROPEAN COMMISSION FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BPH (BENIGN PROSTATIC HYPERPLASIA) Milan, 3 February 2010 - Recordati announces that it has been granted Marketing Authorization by the European Commission for the medicinal products Urorec and Silodyx 4 mg, 8 mg, hard capsules ...

Discover News | Full Story


RECORDATI : SILODOSIN (UROREC®/SILODYX(TM)) APPROVED BY THE EUROPEAN COMMISSION FOR THE TREATMENT OF THE SIGNS AND ...

Published February 3, 2010, 1:43 am, ITNews

(ITnews) - (Hugin) - RECORDATI : SILODOSIN (UROREC®/SILODYX(TM)) APPROVED BY THE EUROPEAN COMMISSION FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BPH (BENIGN PROSTATIC HYPERPLASIA) Milan, 3 February 2010 - Recordati announces that it has been granted Marketing Authorization by the European Commission for the medicinal products Urorec® and Silodyx(TM) 4 mg, 8 mg, hard capsules, intended for ...

Discover News | Full Story


Vantia Therapeutics initiates Phase IIb trial of VA106483 for nocturia

Published February 2, 2010, 4:21 am, News-Medical-Net

Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, today announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a